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Between the Lotus Transcatheter
Aortic Valve Prosthesis and the
Native Ventricular Aortic Interface by
320-Multidetector Computed Tomography
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MaOBJECTIVES This study sought to assess the geometric interaction between the Lotus Valve System transcatheter
aortic prosthesis (Boston Scientiﬁc, Natick, Massachusetts) and the native aortoventricular interface using multidetector
computed tomography (MDCT).
BACKGROUND The interaction between transcatheter aortic valve prostheses and native anatomy is variable, although
potentially predictable. The Lotus transcatheter device uses a novel mechanical means of expansion, the effect of which
on native anatomic geometry has not previously been described.
METHODS Forty patients treated with the Lotus prosthesis were enrolled. The patients underwent 320-MDCT imaging
before and after implantation. Prosthesis dimensions and relevant interaction parameters, including circularity and
expansion, were assessed. The degree of paraprosthetic regurgitation (PAR) and prosthesis gradient were measured by
transthoracic echocardiography at the same time points.
RESULTS The mean baseline annular eccentricity index (EI) was 0.21  0.06 and left ventricular outﬂow tract EI was
0.31  0.09. The deployed prostheses had high rates of circularity with a mean EI across all device segments of 0.06 
0.04. In noncircular device deployment, an EI >0.1 was identiﬁed in 25% of prostheses and was associated with greater
native annular eccentricity at baseline compared with circular devices (0.24  0.04 vs. 0.19  0.06; p ¼ 0.01). The
median percent of expansion was 97.5  3.8% in the inﬂow portion of the prosthesis. Twenty-ﬁve percent of prostheses
were <90% expanded in at least 1 segment with a numerical, but not statistically signiﬁcant, association between
oversizing and underexpansion. No correlation was found between device underexpansion and the mean transprosthesis
gradient or between noncircularity and PAR.
CONCLUSIONS The Lotus prosthesis results in nearly full device expansion and circularization of the native basal plane.
Awareness of the anatomic interaction between this unique device and the native architecture may help in the formu-
lation of appropriate device-speciﬁc sizing algorithms. (J Am Coll Cardiol Intv 2015;8:740–9) © 2015 by the American
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AB BR E V I A T I O N S
AND ACRONYM S
EI = eccentricity index
LVOT = left ventricular
outﬂow tract
MDCT = multidetector
computed tomography
PAR = paraprosthetic aortic
regurgitation
TAVR = transcatheter aortic
valve replacement
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741Successful TAVR relies on accurate pre-procedural
imaging to appropriately size the transcatheter pros-
thesis. Improved pre-procedural sizing, including the
use of 3-dimensional multiple detector computed
tomography (MDCT)–based screening, has contrib-
uted to a reduction in complications such as para-
prosthetic aortic regurgitation (PAR) (1–3), pacing
requirement (4), device embolization, and annular
injury (5).
Although much focus has been on 3-dimensional
pre-procedural assessment, equally important in
ensuring procedural efﬁcacy and safety is an aware-
ness of the interaction that a given TAVR device
might have with the native anatomy. Self-expanding
prostheses such as the CoreValve (Medtronic, Min-
neapolis, Minneapolis), when positioned in a noncir-
cular native annulus, tend to remain slightly
eccentric (6). Balloon-expandable prostheses, how-
ever, such as the SAPIEN valve (Edwards Lifesciences,
Irvine, California) tend to circularize even an eccen-
tric native annulus (7,8).
Awareness of this variability in device-annulus
interaction is important in determining what degree
of prosthesis oversizing is efﬁcacious yet safe.
Deploying a device of slightly larger area or perimeter
than the native annulus, i.e., oversizing, has been
used with the current generation of devices to ensure
device stability and help minimize PAR (1). This
approach must be balanced against overdistention of
the annulus and outﬂow tract with an increased risk
of annular injury and/or pacing requirement. Over-
sizing may equally result in an underexpanded or
noncircular prosthesis, which may, in turn, lead to
accelerated valve wear.
The interaction of the Lotus Valve System (Boston
Scientiﬁc, Natick, Massachusetts) with its unique
expansion and locking mechanism (9) (Figure 1A) with
the native annulus has not previously been described.
Description and quantiﬁcation of this relationship
will help in the development of appropriate sizing
algorithms for this novel device.
METHODS
POPULATION. Forty patients undergoing TAVR using
the Lotus Valve System at our cardiac center were
prospectively enrolled. All patients were being
treated for symptomatic severe aortic stenosis and
had been deemed to be at high surgical risk by the
institution’s heart team. An independent case review
committee reviewed all cases before acceptance into
the trial. All patients met the previously reported
inclusion and exclusion criteria for the Boston
Scientiﬁc REPRISE (Repositionable PercutaneousReplacement of Stenotic Aortic Valve
Through Implantation of Lotus Valve System)
trials (10). This study formed a single-center
substudy within the REPRISE trials. Ethics
approval was obtained from the institutional
Human Research Ethics Committee.
IMAGING. All subjects underwent retrospec-
tively electrocardiography-gated, 320-MDCT
imaging of the aortic root before device im-
plantation. Twenty-ﬁve patients subse-
quently underwent imaging at 32.7  1.2 days,
and 15 patients underwent imaging at 384.5  11.4
days after implantation. All scans were performed on
a Toshiba Aquilion One 320-detector row scanner
(Toshiba Medical Systems, Otawara, Japan). No heart
rate control was used. Seventeen scans were per-
formed using prospective electrocardiographic gating
with a temporal window between 75% and 85% of the
R-R interval, whereas 23 scans used a retrospective
(full R-R interval) window. Collimation was individ-
ualized to achieve a z-axis that encompassed the
entire aortic root. The slice thickness was 0.5 mm.
The gantry rotation speed was 275 ms per rotation,
the tube voltage was 100 to 120 kV, and the tube
current individualized to body habitus.
MDCT ANALYSIS. Pre-procedural imaging. All scans were
analyzed using the 3Mensio Structural Heart
analysis program, version 7 (3Mensio, Bilthoven, the
Netherlands) and the Vitrea Fx workstation (Vital
Images, Minneapolis, Minnesota).
The aortic valve basal plane was deﬁned as the
short-axis plane through the nadir of each coronary
cusp. The minimal diameter (Dmin), maximal diam-
eter (Dmax), perimeter, and area were measured in
this short axis. The circularity of the basal plane was
expressed as the eccentricity index [EI ¼ 1 
(Dmin/Dmax)]. This metric was previously demon-
strated to correlate with post-procedural aortic
regurgitation (3).
The left ventricular outﬂow tract (LVOT) was
assessed in the short-axis 4 mm below the basal plane,
perpendicular to the center line. Minimal andmaximal
diameters, perimeter, and area were measured at this
level, with the eccentricity expressed as the EI. The
sinus of Valsalva width, perimeter, and area were
measured at the widest point of the sinus. The height
of each coronary sinus was measured from the basal
plane to the sinotubular junction in a stretched mul-
tiplanar image. The coronary artery heights were
measured from the basal plane to the lowest border
of each coronary ostia in a stretched multiplanar
image. The angulation of the aortic valve plane
was measured in relation to the horizontal plane.
FIGURE 1 Lotus TAVR Prosthesis
Lotus Valve System transaortic valve replacement (TAVR) prosthesis (Boston Scientiﬁc, Natick, Massachusetts). (A) Components. (B) Lotus
prosthesis dimensions.
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742The degree of calciﬁcation at the level of the LVOT
and basal plane was semiquantitatively graded
as none, mild (1 nodule protruding <5 mm and
covering <10% of the perimeter), moderate (2 nodules
or 1 nodule protruding more than 5 mm or covering
more than 10% of the perimeter), or severe (multiple
nodules or a single nodule protruding more than 1 cm
or covering more than 20% of the perimeter), and the
distribution of calciﬁcation in relation to the coronary
cusps was assessed as previously reported (5).
Prostheses were sized on the basis of baseline
MDCT measurements and manufacturer recommen-
dations for the REPRISE trials. Two device sizes were
available, 23 mm was used for derived annular di-
ameters 18 to 23 mm and 27 mm was used for derived
annular diameters 23 to 27 mm (Figure 1B).
Post-procedura l imaging. The same MDCT scan-
ning protocol was used for post-procedural 320-
MDCT scans. The prosthesis was identiﬁed, and a
short axis plane was positioned through the aortic
aspect of the 3 locking mechanisms. The locking
mechanisms were chosen because they remain at a
stable outﬂow position, whereas the inﬂow edge ofthe frame may adopt a more variable depth along its
circumference when the device is oversized. A center
line perpendicular to the prosthesis was generated.
The maximal and minimal prosthesis diameters
were measured in the short axis at 3 levels (inﬂow,
mid-prosthesis, outﬂow). At each level, the circu-
larity, expressed as the EI, was calculated with an
EI >0.10 considered to be noncircular, in keeping
with previously published studies investigating other
TAVR devices. The percent of expansion of the device
(MDCT-derived prosthesis area/nominal prosthesis
area  100) was also calculated at each level, with a
percent of expansion <90% considered under-
deployed. The prosthesis frame height and depth of
implant in relation to the nadir of the sinus of Val-
salva were measured in the stretched multiplanar
image.
The height of the coronary arteries was measured
from the inﬂow edge of the TAVR prosthesis, noting
whether the stent frame extended beyond their
origin. In instances in which the coronary arteries
were behind the stent frame, the difference between
cross-sectional area of the sinus of Valsalva and the
TABLE 2 Baseline MDCT Dimensions and Procedural
Characteristics (N ¼ 40)
Basal plane
Dmin, mm 21.0  1.8
Dmax, mm 26.6  2.1
Perimeter, mm 75.3  5.7
Area, mm2 431.8  65.8
Eccentricity index 0.21  0.06
LVOT
Dmin, mm 18.8  2.5
Dmax, mm 27.3  2.3
Perimeter, mm 74.1  6.4
Area, mm2 399.4  76.2
Eccentricity index 0.31  0.09
Sinus of Valsalva
2
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743cross-sectional area of the prosthesis at the level of
the coronary artery was measured. This gave an
estimate of the adequacy of the sinus volume to
accommodate the prosthesis but avoid coronary
obstruction.
The degree of prosthesis-tissue interaction at the
level of the annulus and LVOT was qualitatively
assessed, and the percent of prosthesis circumference
nonapposed was calculated.
The 23 scans performed with a retrospective pro-
tocol were analyzed in systole (20% to 30% R-R
interval) and diastole (75% to 85% R-R interval) to
assess for prosthesis deformation during the cardiac
cycle. A blinded observer assessed the leaﬂet mobility
and thickness in these scans using multiplanar
3-dimensional reformations on the Vitrea Fx work
platform (Vital Images). Comparison was made
between circular and noncircular prostheses and
between the 30-day and 1-year time points.
TRANSTHORACIC ECHOCARDIOGRAPHY. All patients
underwent transthoracic echocardiography at base-
line and at the same time point as the post-procedural
MDCT scan. All transthoracic echocardiography scans
were performed using a Vivid 7 (GE Healthcare, Mil-
waukee, Wisconsin). An independent echocardio-
graphy core laboratory assessed all scans for
measurement of transprosthesis gradient and degree
of PAR.
STATISTICAL ANALYSIS. Categorical variables were
expressed as frequencies and percents, and contin-
uous variables were expressed as means and SDs.
Categorical variables were compared using a chi-
square test, and nonparametric continuous variables
were compared using the paired-sample Student
t test. A 2-sided p value <0.05 was considered statis-
tically signiﬁcant. Statistical analysis was performedTABLE 1 Baseline Characteristics (N ¼ 40)
Male 13 (32.5)
Age, yrs 83.5  5.0
Height, m 1.61  0.10
Weight, kg 73.5  17.4
BMI, kg/m2 28.5  6.7
STS PROM 5.7  2.6
EuroSCORE II 7.7  6.6
LVEF, % 57.7  11.5
AVA, mm2 0.73  0.18
Mean aortic gradient, mm Hg 47.7  11.9
Values are n (%) or mean  SD.
AVA ¼ aortic valve area; BMI ¼ body mass index; EuroSCORE ¼ European
System for Cardiac Operative Risk Evaluation; LVEF ¼ left ventricular ejection
fraction; STS PROM ¼ Society of Thoracic Surgeons Predicted Risk of Mortality
Score.using IBM SPSS Statistics version 22.0 (IBM Corpora-
tion, New York, New York).
RESULTS
POPULATION. Forty patients (32.5% male) who were
undergoing TAVR using the Lotus Valve System were
prospectively enrolled. The mean age was 83.5 
5.0 years, and the mean Society of Thoracic Surgeons
mortality risk score was 5.7  1.2%. Baseline charac-
teristics are outlined in Table 1.
All patients had successful implantation of a single
Lotus prosthesis. Eighteen patients (45.0%) received
a 27-mm device, and the remainder were treated with
a 23-mm device.
MDCT ASSESSMENT. Baseline assessment. An experi-
enced computed tomography cardiologist adjudi-
cated all scans to be of good quality with adequate
contrast opaciﬁcation and minimal temporal artifact.
The mean eccentricity during the systolic phase at
the level of the basal plane was 0.21  0.06 andArea, mm 753.4  104.6
Average height, mm 21.1  1.6
Coronary artery height, mm
LMCA 15.2  2.8
RCA 17.0  2.5
Procedure
Implanted prosthesis size, 23/27 mm 22/18
New pacemaker implantation 11 (27.5)
PAR at 30 days
None/trivial 35 (87.5)
Mild 5 (12.5)
Moderate 0 (0)
Severe 0 (0)
Mean gradient at follow-up, mm Hg 11.9  5.1
Values are n (%) or mean  SD.
Dmax ¼ maximal diameter; Dmin ¼ minimal diameter; LMCA ¼ left main coronary
artery; LVOT ¼ left ventricular outﬂow tract; MDCT ¼ multidetector computed
tomography; PAR ¼ paraprosthetic aortic regurgitation; RCA ¼ right coronary
artery.
FIGURE 2 Assessment of Calciﬁc Burden and Distribution
(A) Eccentric leaﬂet calciﬁcation. (B) Calciﬁc nodules at the level of the left ventricular outlet tract. (C) Calciﬁc nodules at the level of the basal
plane. (D) Mild leaﬂet calciﬁcation. (E) Moderate leaﬂet calciﬁcation. (F) Heavy leaﬂet calciﬁcation.
TABLE 3
Basal plan
None
Mild
Modera
Severe
LVOT
None
Mild
Modera
Severe
Location i
Left cor
Right co
Noncoro
Values are n
Abbreviat
Gooley et al. J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 8 , N O . 5 , 2 0 1 5
Assessment of the Lotus TAVR Device by MDCT A P R I L 2 7 , 2 0 1 5 : 7 4 0 – 9
7440.31  0.09 at the level of the LVOT. Further baseline
MDCT dimensions throughout the aortoventricular
interface are described in Table 2.
The annular calciﬁcation burden was assessed as
none, mild, moderate, and severe in 45%, 30%, 22.5%,
and 2.5% of patients, respectively. It was also notedAortoventricular Interface Calciﬁcation and Its Relation to PAR and Exp
Entire Cohort
(N ¼ 40)
No/
Minor PAR
(n ¼ 35)
Mild PAR
(n ¼ 5) p Value
Undere
(n ¼
e
18 (45) 18 (51.4) 0 (0) 2 (2
12 (30) 11 (31.4) 1 (20) 6 (6
te 9 (22.5) 5 (14.3) 4 (80) 2 (2
1 (2.5) 1 (2.9) 0 (0) 0.01 0 (0
31 (77.5) 28 (80) 3 (60) 7 (7
5 (12.5) 3 (8.6) 2 (40) 2 (2
te 3 (7.5) 3 (8.6) 0 (0) 1 (1
1 (2.5) 1 (2.9) 0 (0) 0.23 0 (0
f present
onary cusp 8 (88.9) 5 (71.4) 1 (50) 2 (6
ronary cusp 1 (11.1) 0 (0) 1 (50)
nary cusp 6 (66.7) 4 (57.1) 2 (100) 0.45 3 (1
(%).
ions as in Table 2.that annular/leaﬂet calciﬁcation was unevenly
distributed in 30%. LVOT calciﬁcation was assessed
as none, mild, moderate, and severe in 45%, 30%,
22.5%, and 2.5%, respectively, with calciﬁc nodules
located below the left, right, and noncoronary cusps
in 88.9%, 11.1%, and 66.7%, respectively, of thoseansion
xpanded
10)
Fully
Expanded
(n ¼ 30) p Value
Noncircular
(n ¼ 10)
Circular
(n ¼ 30) p Value
0) 16 (53.3) 1 (10) 17 (56.7)
0) 6 (20) 6 (60) 6 (20)
0) 7 (23.3) 2 (20) 7 (23.3)
) 1 (3.3) 0.10 1 (10) 0 (0) 0.01
0) 24 (80) 5 (50) 26 (86.7)
0) 3 (10) 3 (30) 2 (6.7)
0) 2 (6.7) 1 (10) 2 (6.7)
) 1 (3.3) 0.77 1 (10) 0 (0) 0.06
6.7) 6 (100) 3 (60) 2 (50)
0 1 (16.7) 1 (20) 0 (0)
00) 3 (50) 0.52 2 (40) 3 (75) 0.36
TABLE 4 MDCT Assessment of Lotus Prosthesis at Follow-Up
Prosthesis Segment
p Value*Inﬂow Mid Outﬂow Average
23 mm (n ¼ 22)
Dmin, mm 22.0  0.8 22.0  1.0 22.7  0.6 22.2  0.8 0.51
Dmax, mm 23.4  0.5 23.2  0.7 23.5  0.5 23.4  0.6 0.26
Area, mm2 403.9  17.1 401.6  26.7 419.8  12.5 408.4  18.8 0.96
Perimeter, mm 71.5  1.5 71.2  2.4 72.8  1.1 71.8  1.7 0.92
27 mm (n ¼ 18)
Dmin, mm 25.8  0.7 25.1  1.7 26.7  0.9 25.9  1.1 0.89
Dmax, mm 27.7  0.8 26.8  1.1 27.8  0.7 27.4  0.9 0.14
Area, mm2 560.9  19.9 530.1  52.6 587.8  29.0 559.6  38.3 0.06
Perimeter, mm 84.2  1.5 81.9  4.0 81.8  18.8 82.6  8.1 0.08
Eccentricity index 0.07  0.04 0.06  0.05 0.04  0.03 0.06  0.04 0.06
% Expansion 97.5  3.8 94.8  8.0 101.8  4.1 98.0  5.3 0.21
Values are mean  SD. *p Value compares inﬂow and outﬂow values.
Abbreviations as in Table 2.
FIGURE 3 Assessment of Prosthesis Circularity and Expansion
(A) A circular prosthesis with an eccentricity index (EI) ¼ 0.01. (B) An eccentric prosthesis
with EI ¼ 0.18. (C) An evenly expanded prosthesis with no waisting. (D) An underexpanded
prosthesis at the basal plane level with waisting of the device (blue arrows) at this point.
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745patients where calcium was present (Figure 2). No
differences were observed in the severity or location
of calciﬁcation in those with mild PAR compared with
those with none or trivial PAR or between under-
expanded and fully expanded prostheses (Table 3).
Eccentr i c i ty . MDCT-derived prosthesis dimensions
are presented in Table 4. The mean EI was 0.06  0.04
across all prosthesis segments. Ten prostheses and
16 prosthesis segments were found to be noncircular
as deﬁned by an EI >0.10 (range 0.10 to 0.19)
(Figures 3A and 3B). One device was noncircular
throughout the frame height (EI ¼ inﬂow, 0.19; mid,
0.11; outﬂow, 0.12), 3 were eccentric in the mid- and
inﬂow segments, 2 were eccentric only in the mid
segment, whereas the other 4 devices were noncir-
cular in the inﬂow segment but circularized in the
mid- and outﬂow segments.
The native basal plane before implantation was
signiﬁcantly more eccentric among those patients
who had noncircular deployment occur (0.24  0.04)
compared with those with circular deployment
(0.19  0.06) (p ¼ 0.01). Although the baseline LVOT
was also more eccentric in patients with a noncircular
deployment (0.34  0.10 vs. 0.30  0.09), this was not
statistically different (p ¼ 0.25).
Assessment of baseline calciﬁcation as a risk factor
for eccentric deployment revealed that 60% of pa-
tients in whom the device was noncircular had mild
annular calciﬁcation, 20% had moderate, and 10%
had severe, which was signiﬁcantly greater than that
observed in those with circular deployment (20%,
23.3%, and 0%, respectively; p ¼ 0.01). The degree of
LVOT calciﬁcation was numerically greater although
not statistically different (p ¼ 0.06) (Table 3).
Expans ion . The mean percent of frame expansion
was 98.0  5.3%. An underexpanded prosthesis
segment (percent of expansion <90%) was found in
10 patients (Figures 3C and 3D). Five of these patients
also had noncircular deployment. One prosthesis
was underexpanded in the inﬂow segment (86.5%)
and 9 in the mid-segment (71.3% to 87.5%). No
prostheses were underexpanded in the outﬂow
segment. Although underexpanded prostheses were
numerically more oversized than fully expanded
prostheses (area oversizing, 17.3  16.7% vs. 11.6 
10.5%; perimeter oversizing, 5.3  7.4% vs. 3.1 
4.9%), this did not reach signiﬁcance. No signiﬁcant
difference was identiﬁed between the extent of
annular or LVOT calciﬁcation and degree of expan-
sion (Table 3).
Underexpansion was not associated with an in-
crease in mean pressure gradient at 30 days with a
numerically lower, although not statistically signiﬁ-
cant, gradient in this cohort (9.2  4.9 mm Hg in theunderexpanded cohort vs. 12.8  4.9 mm Hg in the
fully expanded cohort, p ¼ 0.06).
Prosthes i s pos i t ion . The mean prosthesis height
was 19.2  0.5 mm, and the mean implantation
depth below the nadir of the coronary sinuses was
FIGURE 4 Assessment of Residual Sinus Area
Assessment of the sinus area surrounding the Lotus prosthesis
(Boston Scientiﬁc, Natick, Massachusetts) at the level of the left
main coronary artery. Blue arrow indicates the distance between
the prosthesis and the left main coronary artery.
TABLE 5 Prosthesis Integrity Throughout the Cardiac Cycle
(n ¼ 23)
Systole Diastole p Value
Inﬂow
Dmin, mm 23.9  1.9 23.6  2.4 0.45
Dmax, mm 25.4  2.1 25.3  2.7 0.70
Area, mm2 479.8  76.4 489.0  76.4 0.46
Perimeter, mm 77.7  6.2 78.5  6.3 0.53
Eccentricity index 0.06  0.04 0.07  0.04 0.30
% Expansion 97.9  3.4 99.8  3.7 0.60
Mid
Dmin, mm 23.5  2.2 23.7  2.1 0.08
Dmax, mm 25.0  2.0 25.1  2.0 0.40
Area, mm2 465.6  79.4 466.9  74.8 0.65
Perimeter, mm 76.5  6.4 76.8  5.9 0.20
Eccentricity index 0.06  0.05 0.05  0.05 0.56
% Expansion 95.2  8.1 95.6  8.1 0.45
Outﬂow
Dmin, mm 24.5  2.1 24.7  2.1 0.09
Dmax, mm 25.4  2.3 25.4  2.4 0.92
Area, mm2 494.0  87.0 493.2  88.2 0.87
Perimeter, mm 78.7  7.0 78.8  7.0 0.87
Eccentricity index 0.04  0.03 0.03  0.03 0.66
% Expansion 100.6  4.3 100.4  4.0 0.81
Values are mean  SD.
Abbreviations as in Table 2.
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7463.6  1.2 mm. The prosthesis protruded above the left
main coronary artery in 65.0% of patients and above
the right coronary artery in 40.0%. In patients who
had the coronary ostia beneath the aortic frame edge,
a mean difference of 298.5  91.2 mm2 remained be-
tween the sinus area and prosthesis area at this point,
with a mean distance of 5.2  1.6 mm from the
coronary artery ostium to the prosthesis edge
(Figure 4).
No contrast could be identiﬁed between the pros-
thesis and native tissue at either the annular or
LVOT level, indicating complete apposition of all
prostheses.
Prosthes i s integr i ty throughout the card iac
cyc le . There were no signiﬁcant changes in prosthesis
dimensions, circularity, or expansion throughout
the cardiac cycle in the 23 patients who underwent
retrospectively gated MDCT scanning (Table 5).
Leaﬂet excursion was symmetrical and without
restriction in all 23 patients. Neither leaﬂet calciﬁca-
tion nor thickening was identiﬁed in any prostheses;
in addition, no difference was found between
underexpanded and fully expanded prostheses.
Blinded comparison of prostheses at 30 days and
1 year found no difference in leaﬂet function during
the cardiac cycle or leaﬂet morphology.
Echocard iograph ic assessment of prosthes i s
funct ion . At follow-up, 35 patients (87.5%) had none
or minor PAR, 5 patients (12.5%) had mild, and therewere no patients with moderate or greater PAR. In the
5 patients with mild PAR, 4 (80%) had moderate and 1
(20%) mild basal plane calciﬁcation compared with
14.3% and 31.4%, respectively, in those with none or
minor PAR (p ¼ 0.01) (Table 3).
No association was found between noncircular
deployment and the presence of PAR with 4 cases of
mild PAR in devices that were circularly deployed
(EI <0.10) and only 1 case of mild PAR in the more
eccentric cohort (EI >0.10) (p ¼ 0.84). The mean
transprosthetic gradient at follow-up was 11.9 
5.1 mm Hg. There was no correlation between
underexpansion and the severity of this gradient
(9.2  4.9 mm Hg vs. 12.8  4.9 mm Hg; p ¼ 0.06).
DISCUSSION
Previous post-TAVR imaging studies demonstrated
that balloon-expandable devices result in circulari-
zation of the native annulus (7,8), whereas similar
studies of self-expanding devices suggest that the
prostheses remain more eccentric when deployed in
eccentric annuli (6). The Lotus transcatheter heart
valve uses a unique mechanism of deployment,
expansion and locking, the effect of which on the
prosthesis–native aortoventricular interface interac-
tion was previously unknown.
FIGURE 5 Interaction Between Native Annular Eccentricity and Prosthesis Eccentricity
(A) Change from baseline annular eccentricity to prosthesis eccentricity at inﬂow level. (B) Change from baseline annular eccentricity to prosthesis eccentricity at
mid-level. (C) Change from baseline annular eccentricity to prosthesis eccentricity at outﬂow level.
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 8 , N O . 5 , 2 0 1 5 Gooley et al.
A P R I L 2 7 , 2 0 1 5 : 7 4 0 – 9 Assessment of the Lotus TAVR Device by MDCT
747A number of published case studies following pa-
tients with underexpanded or noncircular prostheses
suggested that even in these cases, good short-term
function and durability are achieved (11,12). There
are no large-scale in vivo studies that assessed
possible deleterious effects of abnormal transcatheter
prosthesis deployment, eccentricity, or underex-
pansion. In vitro computational data, however, indi-
cate that noncircularity of surgically implanted
bioprostheses may lead to increased mechanical
stress on the valve leaﬂets and higher rates of valve
incompetence (13). It is, therefore, possible, although
not proven, that noncircular deployment of TAVR
prostheses may also lead to earlier degeneration and
that prostheses that obtain high rates of circular
expansion may be more durable.
ECCENTRICITY. This study demonstrates that the
Lotus TAVR prosthesis results in high rates of circu-
lar deployment at all prosthesis levels (EI ¼ 0.05 
0.04) even in the presence of signiﬁcant baseline
annular eccentricity (EI ¼ 0.21  0.06). The pros-
thesis was noncircular (EI >0.10) at follow-up in 10
patients in a total of 16 segments (range 0.10 to 0.19)
(Figure 5). Patients who had noncircular deployment
occur had a signiﬁcantly more eccentric native basal
plane at baseline than those who had the prosthesis
circularly deployed. This suggests that greater base-
line eccentricity at the annular level may result in
noncircular prosthesis deployment and should be
factored into pre-procedural anatomic assessment. It
should, however, be recognized that the greatestprosthesis EI was only 0.19, which equates to a dif-
ference of 4.5 mm between the minimal and maximal
diameters.
We also identiﬁed a signiﬁcantly greater burden of
annular calciﬁcation and a trend toward greater LVOT
calciﬁcation in those with noncircular deployment.
Previous studies indicated that the severity of aortic
valve calciﬁcation (14,15) or the degree of calciﬁcation
in the landing zone of the device (16) is associated
with PAR. Whether this association is due to eccen-
tricity of the deployed device from calcium in-
vaginating the frame or preventing symmetrical
deployment has not been proven. In our cohort, we
observed a greater burden of eccentric leaﬂet and
deployment site calciﬁcation in patients in whom the
deployed prosthesis was noncircular. This result
should be interpreted carefully given the small
number of cases of PAR.
Although prosthesis eccentricity has been linked
with PAR (1) in other device studies, we did not
observe such a relationship in our cohort. There were
very low rates of PAR with only 5 cases (12.5%) of mild
PAR and no cases of moderate or greater PAR.
Although this could be attributable to the tendency of
the Lotus TAVR prosthesis to circularize the annulus,
this device also has an adaptive seal around the lower
half of the frame (Figure 1) that is designed to
accommodate any residual interstices after deploy-
ment and thus reduce PAR. The potential efﬁcacy of
the adaptive seal was also observed in the lack of
contrast between the valve frame and native tissue,
indicating nearly complete apposition.
PERSPECTIVES
The interaction between transcatheter aortic valve
prostheses and native anatomy is variable, although
potentially predictable. The Lotus transcatheter de-
vice uses a novel mechanical means of expansion, the
effect of which on native anatomic geometry has not
been previously described. The Lotus device results in
high rates of native annulus circularization and pros-
thesis expansion. The clinical effects of these geo-
metric interactions should be tested in larger
randomized trials.
Gooley et al. J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 8 , N O . 5 , 2 0 1 5
Assessment of the Lotus TAVR Device by MDCT A P R I L 2 7 , 2 0 1 5 : 7 4 0 – 9
748EXPANSION. We identiﬁed 10 prostheses (25%) that
were underexpanded, 1 in the inﬂow segment and 9
in the mid-segment. Underexpansion of SAPIEN
devices has previously been shown to occur most
commonly in the inﬂow segment, correlating with
the more constrained LVOT/annular level (7); how-
ever, underexpansion was much more common in
the middle of the frame height in our cohort. This
may be due in part to the unique locking mechanism
of the Lotus prosthesis, whereby the valve frame is
not forcibly balloon expanded but shortens along
3 evenly spaced mandrels. The more rigid locking
attachments are at the inﬂow and outﬂow por-
tions of the frame with only the thin mandrels
running between these points. This may provide
greater opportunity for incomplete expansion of the
mid-frame.
Although signiﬁcant oversizing of the prosthesis
would conceivably result in underexpansion, such a
correlation was not proven in our cohort. Although
there was numerically greater oversizing in these 10
patients, this difference was not statistically signiﬁ-
cant (area oversizing, 17.3  16.7% vs. 11.6  10.5%;
p ¼ 0.33). Similarly there was no increase in trans-
prosthesis mean gradient as a result of under-
expansion in this cohort with a nonsigniﬁcant,
numerically lower gradient in the underexpanded
devices (9.2  4.9 mm Hg in the underexpanded
cohort vs. 12.8  4.9 mm Hg in the fully expanded
cohort; p ¼ 0.06).
CORONARY POSITION. Contrary to some devices,
the Lotus pre-procedural sizing protocol does not
dictate a speciﬁc minimal required distance between
the annulus and coronary ostia, but rather mandates a
combined assessment together with sinus of Valsalva
height, sinus of Valsalva area, calciﬁc burden, and
calciﬁcation distribution. Despite the prosthesis
extending above the coronary ostia in 28 patients
(70%), there were no instances of coronary obstruc-
tion, with a mean residual sinus area of 298.5 
91.2 mm2 and a mean of 5.2  1.6 mm between the
frame and coronary ostia.
STUDY LIMITATIONS. This must be considered a
pilot study with a modest study population that
makes it difﬁcult to determine associations betweenthe native anatomic features and resultant pros-
thesis deployment or between the prosthesis
deployment and resultant valve hemodynamics.
Similar studies assessing other TAVR prostheses by
MDCT have, however, had similar or even smaller
population sizes. These limited studies are, however,
important in furthering the understanding of phy-
sicians regarding the interaction that each device
type has with the native architecture and the effects
this has on procedural sizing, device function, and
safety.
CONCLUSIONS
The Lotus transcatheter prosthesis results in high
rates of full expansion and appears to result in
circularization of the native annulus with low trans-
prosthesis gradients and minimal PAR. Awareness
of these features may aid in the formulation of
appropriate sizing algorithms that use the idea of
right sizing rather than oversizing to ensure appro-
priate annular occupation, circularity, and expansion
while minimizing procedural and post-procedural
complications.
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